摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(环己基氨基)-2H-1-苯并吡喃-2-酮 | 127202-76-0

中文名称
4-(环己基氨基)-2H-1-苯并吡喃-2-酮
中文别名
——
英文名称
4-cyclohexylaminocoumarin
英文别名
4-(Cyclohexylamino)chromen-2-one
4-(环己基氨基)-2H-1-苯并吡喃-2-酮化学式
CAS
127202-76-0
化学式
C15H17NO2
mdl
——
分子量
243.305
InChiKey
RLIXVONFOXAXLN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    193-195 °C
  • 沸点:
    424.2±34.0 °C(Predicted)
  • 密度:
    1.18±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    4-(环己基氨基)-2H-1-苯并吡喃-2-酮2-甲基苄溴 反应 8.0h, 以51%的产率得到4-cyclohexylamino-3-(2-methyl-benzyl)-chromen-2-one
    参考文献:
    名称:
    Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells
    摘要:
    A number of coumarins exhibit interesting pharmacological activities and are therefore of therapeutic use. We report here the synthesis and the structural analysis of new N-substituted 4-amino-3-(2-methylbenzyl)coumarins (compounds 8a-8e) that present structural analogies with estrothiazine and 11- or 7-substituted 17 beta-estradiol. These derivatives were tested with respect to estrogenic activity on the estrogen receptor positive (ER+) human MCF-7 breast cancer cell line. Two of the reported compounds (8a and 8b) stimulated specifically the proliferation of MCF-7 cells, but not that of estrogen receptor negative (ER-) human MDA-MB-231 breast cancer cells, suggesting that their mitogenic activity is mediated by ER. Accordingly, the stimulating effect of 8a and 8b was suppressed by the pure antiestrogen fulvestrant. Besides, 8a and 8b induced ER down-regulation similar to that produced by classical ER agonists or pure antagonists. The effects of the compounds under study on ER-mediated transcription were assessed on (ER+) MVLN cells, that is, MCF-7 cells stably transfected with a pVit-tk-Luc reporter plasmid. Derivatives 8a and 8b, and surprisingly compound 8c, enhanced ER-mediated gene transactivation in that model. Finally, no coumarin was able to compete with tritiated 17 beta-estradiol ([H-3]E-2) for ER binding, suggesting unconventional interactions with the receptor, such as interactions with the second binding pocket or with the coactivator-binding region. To conclude, observations performed in this study on compound 8c reveal that estrogenic activity can be dissociated from enhancement of cell proliferation. Furthermore, ERE-driven transactivation of transcription seems to be a condition necessary, but not sufficient, for estrogen-induced stimulation of cell growth. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.01.025
  • 作为产物:
    描述:
    4-羟基香豆素环己胺 反应 0.01h, 以92%的产率得到4-(环己基氨基)-2H-1-苯并吡喃-2-酮
    参考文献:
    名称:
    Chavan, Abhijit P., Journal of Chemical Research, 2006, # 3, p. 179 - 181
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Facile and eco-friendly synthesis of chromeno[4,3-b]pyrrol-4(1H)-one derivatives applying magnetically recoverable nano crystalline CuFe<sub>2</sub>O<sub>4</sub> involving a domino three-component reaction in aqueous media
    作者:Moumita Saha、Koyel Pradhan、Asish R. Das
    DOI:10.1039/c6ra06979g
    日期:——
    Nanocrystalline CuFe2O4 catalyzed one pot three component synthesis of chromeno[4,3-b]pyrrol-4(1H)-one derivatives has been achieved in aqueous media. The reaction between the essential building blocks (amine, glyoxal monohydrate and 4-aminocoumarin) has been performed at low catalyst loading, leading to a high yield of the desired heterocyclic scaffold. CuFe2O4 magnetic nanoparticles were prepared
    纳米晶CuFe 2 O 4在水性介质中催化一锅三组分合成铬诺[4,3 - b ]吡咯-4(1 H)-一衍生物。基本组成部分(胺,乙二醛一水合物和4-氨基香豆素)之间的反应已在低催化剂负载量下进行,从而导致所需杂环骨架的高收率。采用简单有效的柠檬酸络合物法制备了CuFe 2 O 4磁性纳米粒子,并利用XRD,FT-IR,EDX,TEM和HRTEM进行了表征。催化剂的易于回收和再利用以及该方法的操作简单性使该方案具有吸引力,可持续性和经济性。
  • Synthesis of 4-(Monoalkylamino)-coumarins
    作者:Ivo C. Ivanov、Stoyan K. Karagiosov、Ilia Manolov
    DOI:10.1002/ardp.19913240118
    日期:——
  • BADRAN, M. M.;EL-ANSARI, A. K.;EL-MELIGIE, S., EGYPT. J. PHARM. SCI., 30,(1989) N-4, C. 379-387
    作者:BADRAN, M. M.、EL-ANSARI, A. K.、EL-MELIGIE, S.
    DOI:——
    日期:——
  • IVANOV, IVO C.;KARAGIOSOV, STOYAN K.;MANOLOV, ILIA, ARCH. PHARM., 324,(1991) N, C. 61-62
    作者:IVANOV, IVO C.、KARAGIOSOV, STOYAN K.、MANOLOV, ILIA
    DOI:——
    日期:——
  • BADRAN, M. M.;EL-ANSARI, A. K.;EL-MELIGIE, S., REV. ROUM. CHIM., 35,(1990) N, C. 777-783
    作者:BADRAN, M. M.、EL-ANSARI, A. K.、EL-MELIGIE, S.
    DOI:——
    日期:——
查看更多